Also, numerous studies have shown platinum-based combination chemotherapy and combination ICIs, like PD-1 or for its ligand PD-L1, can markedly prolong survival in patients with stage III unresectable NSCLC (204–207). This evidence concerns the gene CD274 and non-small cell lung carcinoma.